Cargando…
Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the AGA Institute
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492393/ https://www.ncbi.nlm.nih.gov/pubmed/36152898 http://dx.doi.org/10.1016/j.cgh.2022.09.011 |
| _version_ | 1784793470317101056 |
|---|---|
| author | Hashash, Jana G. Desai, Aakash Kochhar, Gursimran S. Farraye, Francis A. |
| author_facet | Hashash, Jana G. Desai, Aakash Kochhar, Gursimran S. Farraye, Francis A. |
| author_sort | Hashash, Jana G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9492393 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | by the AGA Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94923932022-09-22 Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study Hashash, Jana G. Desai, Aakash Kochhar, Gursimran S. Farraye, Francis A. Clin Gastroenterol Hepatol Research Letter by the AGA Institute 2023-03 2022-09-22 /pmc/articles/PMC9492393/ /pubmed/36152898 http://dx.doi.org/10.1016/j.cgh.2022.09.011 Text en © 2023 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Research Letter Hashash, Jana G. Desai, Aakash Kochhar, Gursimran S. Farraye, Francis A. Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study |
| title | Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study |
| title_full | Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study |
| title_fullStr | Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study |
| title_full_unstemmed | Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study |
| title_short | Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study |
| title_sort | efficacy of paxlovid and lagevrio for covid-19 infection in patients with inflammatory bowel disease: a propensity-matched study |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492393/ https://www.ncbi.nlm.nih.gov/pubmed/36152898 http://dx.doi.org/10.1016/j.cgh.2022.09.011 |
| work_keys_str_mv | AT hashashjanag efficacyofpaxlovidandlagevrioforcovid19infectioninpatientswithinflammatoryboweldiseaseapropensitymatchedstudy AT desaiaakash efficacyofpaxlovidandlagevrioforcovid19infectioninpatientswithinflammatoryboweldiseaseapropensitymatchedstudy AT kochhargursimrans efficacyofpaxlovidandlagevrioforcovid19infectioninpatientswithinflammatoryboweldiseaseapropensitymatchedstudy AT farrayefrancisa efficacyofpaxlovidandlagevrioforcovid19infectioninpatientswithinflammatoryboweldiseaseapropensitymatchedstudy |